MSc (Neuropharmacology)
Attempting to find new drug treatments central nervous system (CNS) diseases is a major global priority. This requires a collaboration between pharmaceutical companies, hospitals and academic institutions. It involves: The identification of drug targets in the CNS disease state of interest Discovery and preclinical profiling of substances acting on this drug target The clinical evaluation for efficacy and safety. The Discipline of Pharmacology and Therapeutics has been actively engaged in neuropharmacological research for over 30 years. In 1998, the MSc in Neuropharmacology was introduced to provide students with the skills necessary to develop a career in important area of research.

Description
Attempting to find new drug treatments central nervous system (CNS) diseases is a major global priority. This requires a collaboration between pharmaceutical companies, hospitals and academic institutions. It involves: The identification of drug targets in the CNS disease state of interest Discovery and preclinical profiling of substances acting on this drug target The clinical evaluation for efficacy and safety. The Discipline of Pharmacology and Therapeutics has been actively engaged in neuropharmacological research for over 30 years. In 1998, the MSc in Neuropharmacology was introduced to provide students with the skills necessary to develop a career in important area of research.
Intakes
September Intake 2025 ( Open )
English Test Scores
- IELTS (International English Language Testing System) [ 6.5 ]
- PTE (Pearson Test of English) [ 55 ]
- TOEFL Internet Based [ 79 ]